BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33963218)

  • 1. Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461.
    Masud T; Soong C; Xu H; Biele J; Bjornson S; McKinney S; Aparicio S
    Sci Rep; 2021 May; 11(1):9812. PubMed ID: 33963218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
    Xu H; Di Antonio M; McKinney S; Mathew V; Ho B; O'Neil NJ; Santos ND; Silvester J; Wei V; Garcia J; Kabeer F; Lai D; Soriano P; Banáth J; Chiu DS; Yap D; Le DD; Ye FB; Zhang A; Thu K; Soong J; Lin SC; Tsai AH; Osako T; Algara T; Saunders DN; Wong J; Xian J; Bally MB; Brenton JD; Brown GW; Shah SP; Cescon D; Mak TW; Caldas C; Stirling PC; Hieter P; Balasubramanian S; Aparicio S
    Nat Commun; 2017 Feb; 8():14432. PubMed ID: 28211448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands.
    Bossaert M; Pipier A; Riou JF; Noirot C; Nguyên LT; Serre RF; Bouchez O; Defrancq E; Calsou P; Britton S; Gomez D
    Elife; 2021 Jun; 10():. PubMed ID: 34180392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
    Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461.
    Jin M; Hurley LH; Xu H
    Bioorg Med Chem Lett; 2023 Jul; 91():129384. PubMed ID: 37339720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage.
    Thorslund T; Ripplinger A; Hoffmann S; Wild T; Uckelmann M; Villumsen B; Narita T; Sixma TK; Choudhary C; Bekker-Jensen S; Mailand N
    Nature; 2015 Nov; 527(7578):389-93. PubMed ID: 26503038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Dynamics Study on the Binding of an Anticancer DNA G-Quadruplex Stabilizer, CX-5461, to Human Telomeric, c-KIT1, and c-Myc G-Quadruplexes and a DNA Duplex.
    Sullivan HJ; Chen B; Wu C
    J Chem Inf Model; 2020 Oct; 60(10):5203-5224. PubMed ID: 32820923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
    Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
    Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage.
    Gatti M; Pinato S; Maiolica A; Rocchio F; Prato MG; Aebersold R; Penengo L
    Cell Rep; 2015 Jan; 10(2):226-38. PubMed ID: 25578731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168.
    Zhu Q; Sharma N; He J; Wani G; Wani AA
    Cell Cycle; 2015; 14(9):1413-25. PubMed ID: 25894431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
    Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
    J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies.
    Hilton J; Gelmon K; Bedard PL; Tu D; Xu H; Tinker AV; Goodwin R; Laurie SA; Jonker D; Hansen AR; Veitch ZW; Renouf DJ; Hagerman L; Lui H; Chen B; Kellar D; Li I; Lee SE; Kono T; Cheng BYC; Yap D; Lai D; Beatty S; Soong J; Pritchard KI; Soria-Bretones I; Chen E; Feilotter H; Rushton M; Seymour L; Aparicio S; Cescon DW
    Nat Commun; 2022 Jun; 13(1):3607. PubMed ID: 35750695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.
    Wu W; Rokutanda N; Takeuchi J; Lai Y; Maruyama R; Togashi Y; Nishikawa H; Arai N; Miyoshi Y; Suzuki N; Saeki Y; Tanaka K; Ohta T
    Cancer Res; 2018 Nov; 78(22):6371-6385. PubMed ID: 30279242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Damage-Induced Foci of E2 Ubiquitin-Conjugating Enzyme are Detectable upon Co-transfection with an Interacting E3 Ubiquitin Ligase.
    Wang D; Tian Y; Wei D; Jing Y; Niu H; Xie K; Song Y
    Biochem Genet; 2016 Apr; 54(2):147-57. PubMed ID: 26718580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF168-mediated H2A neddylation antagonizes ubiquitylation of H2A and regulates DNA damage repair.
    Li T; Guan J; Huang Z; Hu X; Zheng X
    J Cell Sci; 2014 May; 127(Pt 10):2238-48. PubMed ID: 24634510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.
    Stewart GS; Panier S; Townsend K; Al-Hakim AK; Kolas NK; Miller ES; Nakada S; Ylanko J; Olivarius S; Mendez M; Oldreive C; Wildenhain J; Tagliaferro A; Pelletier L; Taubenheim N; Durandy A; Byrd PJ; Stankovic T; Taylor AM; Durocher D
    Cell; 2009 Feb; 136(3):420-34. PubMed ID: 19203578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells.
    McLuckie KI; Di Antonio M; Zecchini H; Xian J; Caldas C; Krippendorff BF; Tannahill D; Lowe C; Balasubramanian S
    J Am Chem Soc; 2013 Jul; 135(26):9640-3. PubMed ID: 23782415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway.
    Pinato S; Gatti M; Scandiuzzi C; Confalonieri S; Penengo L
    Mol Cell Biol; 2011 Jan; 31(1):118-26. PubMed ID: 21041483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex).
    Xu H; Hurley LH
    Bioorg Med Chem Lett; 2022 Dec; 77():129016. PubMed ID: 36195286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF8 E3 Ubiquitin Ligase Stimulates Ubc13 E2 Conjugating Activity That Is Essential for DNA Double Strand Break Signaling and BRCA1 Tumor Suppressor Recruitment.
    Hodge CD; Ismail IH; Edwards RA; Hura GL; Xiao AT; Tainer JA; Hendzel MJ; Glover JN
    J Biol Chem; 2016 Apr; 291(18):9396-410. PubMed ID: 26903517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.